GSK Spotlights Three Impending Drug Launches In 3Q Update

 
• By Lucie Ellis-Taitt

GlaxoSmithKline focused on three upcoming launches for its pharmaceutical business during its Q3 update, during which CEO Emma Walmsley also speculated briefly about acquiring Pfizer's consumer health business.

Launch Plans words stamped in red ink on yellow envelope offering advice, information
GSK 3Q Update: focus falls on new product launches • Source: Shutterstock

More from Earnings

More from Business